case archive
Frontier technology for the future challenges of animal health.
July 2026
Scientific evaluation on Astex and LIT-PCBA
ISR-BIO’s optimized Vina implementation shows a favorable top-1 ranking signal against Python Vina on both datasets.
June 2026
Two campaigns of bactericidal and bacteriostatic activity
Fourteen candidates and a Candidate A + B mix tested against PS011. The lowest observed MIC was 8.03 µg/mL for the mix formulated around their synergy.
October 2025
CORAL AI achieved EF₁%=38.2 in a protein–ligand prioritization benchmark
A hybrid architecture concentrated active compounds within the top-ranked 1%, outperforming the three methods included in the review while preserving a clearly defined computational scope.
January 2025
Immune activation and in vitro cellular protection
Candidates A and B activated IL-1β, IL-8, NF-κB, and IL-12 and reduced damage in infected salmon cells, with distinct functional profiles.
Expand your research capabilities today. Let's go!